MAO activity in serotonergic endings of rat major cerebral arteries

Journal of Physiology and Biochemistry

Volumn 60, Issue 1, 2004, Pages 23-29

  Lopez de Pablo A L ^a   Ajubita, M ^a   Criado, M C F ^a   Marco, Emilio J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cerebral arteries; Clorgyline; Deprenyl; Dorsal raphe nucleus; Monoamine oxidase

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; ISOENZYME; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; SELEGILINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ARTERY; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DORSAL RAPHE NUCLEUS; ELECTROLYSIS; ENZYME ACTIVITY; IN VIVO STUDY; MALE; NERVE ENDING; NONHUMAN; RAT; SEROTONINERGIC NERVE CELL;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 4344575943     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03168217     Document Type: Article

References (23)

1. Arai, R., Kimura, H., Nagatsu, I. and Maeda, T. (1997): Brain Res,, 745, 352-356.
2. Aubineau, P. and Mathiau, P. (1995): Stroke, 26, 139-140.
3. Bonvento, G., MacKenzie, E. T., Fage, D., Benavides, J., Rouquier, L. and Scatton, B. (1991): J. Neurochem., 56, 681-689.
4. Cohen, Z., Bonvento, G., Lacombe, P., Seylaz, J., MacKenzie, E. T. and Hamel, E. (1992): Brain Res., 598, 203-214.
5. Frazer, A. and Hensler, J. G. (1994): In "Basic Neurochemistry". (Siegel, G. J., Agranoff, B. W., Albers, R. W. and Molinoff, P. B., eds.). Raven Press, New York. pp. 283-308.
6. Hardebo, J. E., Emson, P. C., Falck, B., Owman, C. and Rosengren, E. (1980): J. Neurochem., 35, 1388-1393.
7. Jahng, J. W., Houpt, T. A., Wessel, T. C., Chen, K., Shih, J. C. and Job, T. H. (1997): Synapse, 25, 30-36.
8. Kumagae, Y., Matsui, Y. and Iwata, N. (1991): Jpn. J. PharmacoL, 55, 121-128.
9. López de Pablo, A. L., Moreno, M. J. and Marco, E. J. (1996): J. Neurochem., 67, 2060-2065.
10. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951):J. Biol. Chem., 193, 354-357.
11. Luque, J. M., Kwan, S.-W., Abell, C. W., Da Prada, M. and Richards, J. G. (1995): J. Comp. Neurol., 363, 665-680.
12. Mamounas, L. A., Mullen, C. A., O'Hearn, E. and Molliver, M. E. (1991): J. Comp. Neurol., 314, 558-586.
13. Marco, E. J., Moreno, M. J. and López de Pablo, A. L. (1999): Stroke, 30, 1695-1701.
14. Moreno, M. J., López de Pablo, A. L., Conde, M. V., Fraile, M. L. and Marco, E. J. (1994): Rev. esp. FisioL., 50, 175-181.
15. Moreno, M. J., López de Pablo, A. L. and Marco, E. J. (1994): Stroke, 25, 1046-1049.
16. Moreno, M. J., López de Pablo, A. L., Conde, M. V. and Marco, E. J. (1995): Stroke, 26, 271-275: discussion 275-276.
17. Moreno, M. J., López de Pablo, A. L. and Marco, E. J. (1997): Brain Res., 749, 161-163.
18. Neff, N. H., Lin, R. C., Ngai, S. H. and Costa, E. (1969): Adv. Biochem. Psychopharmacol., 1, 91-109.
19. Shigematsu, K., Akiguchi, I, Oka, N., Kamo, H., Matsubyashi, K., Kawamura, J. and Maeda, T. (1989): Brain Res., 497, 21-29.
20. Silver, H. and Youdim, M. B. (2000): Eur. Neuropsychopharmacol., 10, 125-128.
21. Soto, J. C. and Marco, E. J. (1988): J. Pharm. Pharmacol., 40, 185-187.
22. Standaert, D. G. and Young, A. B. (1996): In "Goodman & Gilman's The Pharmacological Basis of Therapeutics". (Hardman, J. G., Gilman, G. and Limbird, L. E., eds.). McGraw-Hill, New York. pp. 503-519.
23. Youdin, M. B. H. and Finberg, J. P. M. (1983): In "Psychopharmacology. Part 1: Preclinical Psychopharmacology". (Grahame-Smith, D. G., Hippius, H. and Winokur, G., eds.). Excerpta Medica, Amsterdam. pp. 38-70.